Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms

doi:10.12998/wjcc.v10.i17.5667

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 17

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3525)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-8) series.

Item

Count

PDF

161

WORD

HTML

1660

Figures (1-4)

356

Tables (1-8)

245

Sum=2481

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

226

Download

810

Sum=1036

Jun 16, 2022 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Jun 16, 2022; 10(17): 5667-5679
Published online Jun 16, 2022. doi: 10.12998/wjcc.v10.i17.5667

Table 2 Baseline and demographic characteristics of patients and cysts: subgroups

		Non-worrisome features (n = 88)	Worrisome features (n = 10)	P value
Males (%)		31 (35.2)	2 (20.0)	0.540234
Females (%)		57 (64.8)	8 (80.0)	0.540234
Median age at diagnosis (IQR)		70 (63.5-74.75)	67 (59.75-76.25)	0.58232
Familial history (%)		8 (9.1)	1 (10.0)	0.628786
History of diabetes (%)		14 (15.9)	2 (20.0)	0.904665
Diabetes onset during follow-up (%)		0 (0.0)	0 (0.0)	-
Median follow-up [mo (IQR)]		37.5 (23.25-71)	69.5 (46.5-94)	0.01828
Former smokers (%)		11 (12.5)	3 (30.0)	0.306885
Active smokers (%)		8 (9.1)	0 (0.0)	0.738111
Never smoked (%)		69 (78.4)	7 (70.0)	0.83833
Multifocal		52 (59.1)	5 (50.0)	0.830551
Largest cyst localization	Head (%)	39 (44.3)	5 (50.0)	0.994538
	Isthmus/body (%)	35 (39.8)	5 (50.0)	0.776364
	Tail (%)	14 (15.9)	0 (0.0)	0.746616
Median cyst size	a [mm (IQR)]	9 (6-13)	19 (11.25-21.25)	0.0035
	b [mm (IQR)]	10 (6-15)	18 (10.75-20.75)	0.00652
	c [mm (IQR)]	9.5 (6-15)	22.5 (12-27.65)	0.00424
EUS		14 (15.9)	5 (50.0)	0.030618
Median time to EUS (IQR)		3 (0-18.25)	29 (5.5-69.5)	0.22628
Serum CA19.9 [IU/L (IQR)], n = 25		6.2 (5.6-24.2)	23.8 (6.2-37.9)	0.1556
Serum CEA [IU/L (IQR)], n = 22		2.15 (1.28-2.93)	2.15 (1.55-2.75)	0.93624

IQR: Interquartile range; a: Sagittal (antero-posterior); b: Transversal (latero-lateral); c: Coronal (cranio-caudal).

Citation: Innocenti T, Danti G, Lynch EN, Dragoni G, Gottin M, Fedeli F, Palatresi D, Biagini MR, Milani S, Miele V, Galli A. Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms. World J Clin Cases 2022; 10(17): 5667-5679
URL: https://www.wjgnet.com/2307-8960/full/v10/i17/5667.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i17.5667